Metal and redox modulation of cysteine protein function

Chemistry and Biology

Volumn 10, Issue 8, 2003, Pages 677-693

  Giles, Niroshini M ^a   Watts, Aaron B ^a   Giles, Gregory I ^a   Fry, Fiona H ^a   Littlechild, Jennifer A ^a   Jacob, Claus ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042915887     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-5521(03)00174-1     Document Type: Review

References (179)

1. Giles N.M., Giles G.I., Jacob C. Multiple roles of cysteine in biocatalysis. Biochem. Biophys. Res. Commun. 300:2003;1-4.
2. Thomas J.A., Mallis R., Sies H. Protein S-thiolation, S-nitrosylation, and irreversible sulfhydryl oxidation. roles in redox regulation Gitler C., Danon A. Cellular Implications of Redox Signalling. 2003;World Scientific Publ, Singapore. 141-174.pp.
3. Harman L.S., Mottley C., Mason R.P. Free-radical metabolites of L-cysteine oxidation. J. Biol. Chem. 259:1984;5606-5611.
4. Giles G.I., Jacob C. Reactive sulfur species. an emerging concept in oxidative stress Biol. Chem. 383:2002;375-388.
5. Jacob C., Giles G.I., Giles N.M., Sies H. Sulfur and selenium. the role of oxidation state in protein structure and function Angew. Chem. Int. Ed. Engl. in press:2003.
6. Kaim W., Schwederski B. The bioinorganic chemistry of the quintessentially toxic metals. Meyer G.N.A. Bioinorganic Chemistry. Inorganic Elements in the Chemistry of Life:1991;John Wiley and Sons, Chichester. 330-350.pp.
7. Bonnet D., Stevens J.M., de Sousa R.A., Sari M.A., Mansuy D., Artaud I. New inhibitors of iron-containing nitrile hydratases. J. Biochem. (Tokyo). 130:2001;227-233.
8. Strop P., Takahara P.M., Chiu H.J., Angove H.C., Burgess B.K., Rees D.C. Crystal structure of the all-ferrous 4Fe-4S (0) form of the nitrogenase iron protein from Azotobacter vinelandii. Biochemistry. 40:2001;651-656.
9. Dobbek H., Svetlitchnyi V., Gremer L., Huber R., Meyer O. Crystal structure of a carbon monoxide dehydrogenase reveals a Ni-4Fe-5S cluster. Science. 293:2001;1281-1285.
10. Ogata H., Mizoguchi Y., Mizuno N., Miki K., Adachi S., Yasuoka N., Yagi T., Yamauchi O., Hirota S., Higuchi Y. Structural studies of the carbon monoxide complex of NiFe hydrogenase from Desulfovibrio vulgaris Miyazaki F. suggestion for the initial activation site for dihydrogen J. Am. Chem. Soc. 124:2002;11628-11635.
11. Peters J.W., Lanzilotta W.N., Lemon B.J., Seefeldt L.C. X-ray crystal structure of the Fe-only hydrogenase (Cpl) from Clostridium pasteurianum to 1.8 angstrom resolution. Science. 282:1998;1853-1858.
12. Furey W.F., Robbins A.H., Clancy L.L., Winge D.R., Wang B.C., Stout C.D. Crystal structure of Cd,Zn metallothionein. Science. 231:1986;704-710.
13. Rees D.C. Great metalloclusters in enzymology. Annu. Rev. Biochem. 71:2002;221-246.
14. Xu D., Rovira I.I., Finkel T. Oxidants painting the cysteine chapel. redox regulation of PTPs Dev. Cell. 2:2002;251-252.
15. Zhong L.W., Arner E.S.J., Holmgren A. Structure and mechanism of mammalian thioredoxin reductase. the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence Proc. Natl. Acad. Sci. USA. 97:2000;5854-5859.
16. Arnér E.S.J., Holmgren A. Physiological functions of thioredoxin and thioredoxin reductase. Eur. J. Biochem. 267:2000;6102-6109.
17. Holmgren A. Thioredoxin structure and mechanism. conformational changes on oxidation of the active-site sulfhydryls to a disulfide Structure. 3:1995;239-243.
18. Pai E.F., Schulz G.E. The catalytic mechanism of glutathione-reductase as derived from X-ray-diffraction analyses of reaction intermediates. J. Biol. Chem. 258:1983;1752-1757.
19. Finkel T., Holbrook N.J. Oxidants, oxidative stress and the biology of ageing. Nature. 408:2000;239-247.
20. Finkel T. Redox-dependent signal transduction. FEBS Lett. 476:2000;52-54.
21. Sies H. Biochemistry of oxidative stress. Angew. Chem. Int. Ed. Engl. 25:1986;1058-1071.
22. Giles G.I., Tasker K.M., Jacob C. Hypothesis. the role of reactive sulfur species in oxidative stress Free Radic. Biol. Med. 31:2001;1279-1283.
23. Nishinaka Y., Masutani H., Nakamura H., Yodoi J. Regulatory roles of thioredoxin in oxidative stress-induced cellular responses. Redox Rep. 6:2001;289-295.
24. Collet J.F., Bardwell J.C.A. Oxidative protein folding in bacteria. Mol. Microbiol. 44:2002;1-8.
25. Persson A.L., Sahlin M., Sjoberg B.M. Cysteinyl and substrate radical formation in active site mutant E441Q of Escherichia coli class I ribonucleotide reductase. J. Biol. Chem. 273:1998;31016-31020.
26. Mustacich D., Powis G. Thioredoxin reductase. Biochem. J. 346:2000;1-8.
27. Kizek R., Trnkova L., Palecek E. Determination of metallothionein at the femtomole level by constant current stripping chronopotentiometry. Anal. Chem. 73:2001;4801-4807.
28. Harlyk C., Nieto O., Bordin G., Rodriguez A.R. Electrochemical study of metallothioneins using cyclic voltammetry. J. Electroanalytic. Chem. 458:1998;199-208.
29. Olafson R.W. Electrochemical characterization of metallothionein metal mercaptide complexes - application of cyclic voltammetry to investigation of metalloproteins. Bioelectrochemistry Bioenergetics. 19:1988;111-125.
30. Hwang C., Sinskey A.J., Lodish H.F. Oxidized redox state of glutathione in the endoplasmic reticulum. Science. 257:1992;1496-1502.
31. Akerboom T.P.M., Bilzer M., Sies H. The relationship of biliary glutathione disulfide efflux and intracellular glutathione disulfide content in perfused rat liver. J. Biol. Chem. 257:1982;4248-4252.
32. Simpkins C., Eudaric P., Torrence C., Zhen Y. Metallothionein-I reduction of cytochrome-C. Life Sci. 53:1993;1975-1980.
33. Stadtman E.R. Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. Annu. Rev. Biochem. 62:1993;797-821.
34. Park O.K., Bauerle R. Metal-catalyzed oxidation of phenylalanine-sensitive 3-deoxy-D-arabino-heptulosonate-7-phosphate synthase from Escherichia coli. inactivation and destabilization by oxidation of active site cysteines J. Bacteriol. 181:1999;1636-1642.
35. Abedinzadeh Z. Sulfur-centered reactive intermediates derived from the oxidation of sulfur compounds of biological interest. Can. J. Physiol. Pharmacol. 79:2001;166-170.
36. Gerlt J.A., Babbitt P.C. Divergent evolution of enzymatic function. mechanistically diverse superfamilies and functionally distinct suprafamilies Annu. Rev. Biochem. 70:2001;209-246.
37. Sun X.Y., Ollagnier S., Schmidt P.P., Atta M., Mulliez E., Lepape L., Eliasson R., Graslund A., Fontecave M., Reichard P.et al. The free radical of the anaerobic ribonucleotide reductase from Escherichia coli is at glycine 681. J. Biol. Chem. 271:1996;6827-6831.
38. Frey P.A. Radical mechanisms of enzymatic catalysis. Annu. Rev. Biochem. 70:2001;121-148.
39. Claiborne A., Mallett T.C., Yeh J.I., Luba J., Parsonage D. Structural, redox, and mechanistic parameters for cysteine-sulfenic acid function in catalysis and regulation. Adv. Protein Chem. 58:2001;215-276.
40. Hofmann B., Hecht H.J., Flohé L. Peroxiredoxins. Biol. Chem. 383:2002;347-364.
41. Georgiou G. How to flip the (redox) switch. Cell. 111:2002;607-610.
42. Ward N.E., Stewart J.R., Ioannides C.G., O'Brian C.A. Oxidant-induced S-gutathiolation inactivates protein kinase C-alpha (PKC-alpha). a potential mechanism of PKC isozyme regulation Biochemistry. 39:2000;10319-10329.
43. Reddy S., Jones A.D., Cross C.E., Wong P.S.Y., van der Vliet A. Inactivation of creatine kinase by S-glutathionylation of the active-site cysteine residue. Biochem. J. 347:2000;821-827.
44. Silva C.M., Cidlowski J.A. Direct evidence for intramolecular and intermolecular disulfide bond formation in the human glucocorticoid receptor - inhibition of DNA-binding and identification of a new receptor-associated protein. J. Biol. Chem. 264:1989;6638-6647.
45. Klatt P., Molina E.P., Lamas S. Nitric oxide inhibits c-Jun DNA binding by specifically targeted S-glutathionylation. J. Biol. Chem. 274:1999;15857-15864.
46. Padron J., Peiro C., Cercas E., Llergo J.L., Sanchez-Ferrer C.F. Enhancement of S-nitrosylation in glycosylated hemoglobin. Biochem. Biophys. Res. Commun. 271:2000;217-221.
47. Mohr S., Hallak H., de Boitte A., Lapetina E.G., Brune B. Nitric oxide induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem. 274:1999;9427-9430.
48. Gergel D., Cederbaum A.I. Inhibition of the catalytic activity of alcohol dehydrogenase by nitric oxide is associated with S nitrosylation and the release of zinc. Biochemistry. 35:1996;16186-16194.
49. Xian M., Wang K., Chen X.C., Hou Y.C., McGill A., Chen X., Zhou B., Zhang Z.Y., Cheng J.P., Wang P.G. Inhibition of protein tyrosine phosphatases by low-molecular-weight S-nitrosothiols and S-nitrosylated human serum albumin. Biochem. Biophys. Res. Commun. 268:2000;310-314.
50. Tenneti L., Demilia D.M., Lipton S.A. Suppression of neuronal apoptosis by S-nitrosylation of caspases. Neurosci. Lett. 236:1997;139-142.
51. Ji Y.B., Akerboom T.P.M., Sies H., Thomas J.A. S-nitrosylation and S-glutathiolation of protein sulfhydryls by S-nitroso glutathione. Arch. Biochem. Biophys. 362:1999;67-78.
52. Kong A.N.T., Yu R., Lei W., Mandlekar S., Tan T.H., Ucker D.S. Differential activation of MAPK and ICE/Ced-3 protease in chemical-induced apoptosis - the role of oxidative stress in the regulation of mitogen-activated protein kinases (MAPKs) leading to gene expression and survival or activation of caspases leading to apoptosis. Restor. Neurol. Neurosci. 12:1998;63-70.
53. Stadtman E.R. Protein oxidation in aging and age-related diseases. Park S.C., Hwang E.S., Kim H.-S., Park W.-Y. Healthy Aging for Functional Longevity, Volume 928. 2001;New York Acad. Sciences, New York. 22-38.pp.
54. Thomas J.A., Mallis R.J. Aging and oxidation of reactive protein sulfhydryls. Exp. Gerontol. 36:2001;1519-1526.
55. Somoza J.R., Palmer J.T., Ho J.D. The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators. J. Mol. Biol. 322:2002;559-568.
56. Premzl A., Zavasnik-Bergant V., Turk V., Kos J. Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro. Exp. Cell Res. 283:2003;206-214.
57. Reverter D., Sorimachi H., Bode W. The structure of calcium-free human m-calpain - implications for calcium activation and function. Trends Cardiovasc. Med. 11:2001;222-229.
58. Brocklehurst K., Watts A.B., Patel M., Verma C., Thomas E.W. Cysteine proteinases. Sonnott M.L. Comprehensive Biological Catalysis, Volume 2. 1998;Academic Press, London. 381-423.pp.
59. Odagaki Y., Hayashi A., Okada K., Hirotsu K., Kabashima T., Ito K., Yoshimoto T., Tsuru D., Sato M., Clardy J. The crystal structure of pyroglutamyl peptidase I from Bacillus amyloliquefaciens reveals a new structure for a cysteine protease. Struct. Fold. Des. 7:1999;399-411.
60. Isupov M.N., Fleming T.M., Dalby A.R., Crowhurst G.S., Bourne P.C., Littlechild J.A. Crystal structure of the glyceraldehyde-3-phosphate dehydrogenase from the hyperthermophilic archaeon Sulfolobus solfataricus. J. Mol. Biol. 291:1999;651-660.
61. Singleton M.R., Isupov M.N., Littlechild J.A. X-ray structure of pyrrolidone carboxyl peptidase from the hyperthermophilic archaeon Thermococcus litoralis. Struct. Fold. Des. 7:1999;237-244.
62. Riedl S.J., Renatus M., Schwarzenbacher R., Zhou Q., Sun C.H., Fesik S.W., Liddington R.C., Salvesen G.S. Structural basis for the inhibition of caspase-3 by XIAP. Cell. 104:2001;791-800.
63. Kim P.K.M., Kwon Y.G., Chung H.T., Kim Y.M. Regulation of caspases by nitric oxide. Deleterious Effects and Clinical Potential, Volume 962 C.C., Chiueh J.-S., Hong, Leong S.K. Nitric Oxide. Novel Actions:2002;New York Acad. Sciences, New York. 42-52.pp.
64. Zeigler M.M., Doseff A.I., Galloway M.F., Opalek J.M., Nowicki P.T., Zweier J.L., Sen C.K., Marsh C.B. Presentation of nitric oxide regulates monocyte survival through effects on caspase-9 and caspase-3 activation. J. Biol. Chem. 278:2003;12894-12902.
65. Mannick J.B., Schonhoff C., Papeta N., Ghafourifar P., Szibor M., Fang K.Z., Gaston B. S-nitrosylation of mitochondrial caspases. J. Cell Biol. 154:2001;1111-1116.
66. Bourne P.C., Isupov M.N., Littlechild J.A. The atomic-resolution structure of a novel bacterial esterase. Struct. Fold. Des. 8:2000;143-151.
67. Noiva R., Lennarz W.J. Protein disulfide isomerase - a multifunctional protein resident in the lumen of the endoplasmic-reticulum. J. Biol. Chem. 267:1992;3553-3556.
68. Buchczyk D.P., Briviba K., Harti F.U., Sies H. Responses to peroxynitrite in yeast. glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a sensitive intracellular target for nitration and enhancement of chaperone expression and ubiquitination Biol. Chem. 381:2000;121-126.
69. Giles G.I., Tasker K.M., Collins C., Giles N.M., O'Rourke E., Jacob C. Reactive sulphur species. an in vitro investigation of the oxidation properties of disulphide S-oxides Biochem. J. 364:2002;579-585.
70. Claiborne A., Miller H., Parsonage D., Ross R.P. Protein-sulfenic acid stabilization and function in enzyme catalysis and gene regulation. FASEB J. 7:1993;1483-1490.
71. Dussault P.H., George A.D., Trullinger T.K. Peroxides as oxidative enzyme inhibitors. mechanism-based inhibition of a cysteine protease by an amino acid ozonide Bioorg. Med. Chem. Lett. 9:1999;3255-3258.
72. Percival M.D., Ouellet M., Campagnolo C., Claveau D., Li C. Inhibition of cathepsin K by nitric oxide donors. evidence for the formation of mixed disulfides and a sulfenic acid Biochemistry. 38:1999;13574-13583.
73. Schmalhausen E.V., Muronetz V.I., Nagradova N.K. Rabbit muscle GAPDH. non-phosphorylating dehydrogenase activity induced by hydrogen peroxide FEBS Lett. 414:1997;247-252.
74. Ishii T., Sunami O., Nakajima H., Nishio H., Takeuchi T., Hata F. Critical role of sulfenic acid formation of thiols in the inactivation of glyceraldehyde-3-phosphate dehydrogenase by nitric oxide. Biochem. Pharmacol. 58:1999;133-143.
75. Schröder E., Littlechild J.A., Lebedev A.A., Errington N., Vagin A.A., Isupov M.N. Crystal structure of decameric 2-Cys peroxiredoxin from human erythrocytes at 1.7 angstrom resolution. Struct. Fold. Des. 8:2000;605-615.
76. Goto K., Holler M., Okazaki R. Synthesis, structure, and reactions of a sulfenic acid bearing a novel bowl-type substituent. the first synthesis of a stable sulfenic acid by direct oxidation of a thiol J. Am. Chem. Soc. 119:1997;1460-1461.
77. Okazaki R., Goto K. Synthesis of highly reactive organosulfur compounds. Heteroatom Chem. 13:2002;414-418.
78. Ishii A., Komiya K., Nakayama J. Synthesis of a stable sulfenic acid by oxidation of a sterically hindered thiol (thiophenetriptycene-8-thiol) and its characterization. J. Am. Chem. Soc. 118:1996;12836-12837.
79. Eklund H., Plapp B.V., Samama J.P., Branden C.I. Binding of substrate in a ternary complex of horse liver alcohol-dehydrogenase. J. Biol. Chem. 257:1982;4349-4358.
80. Pocker Y., Page J.D., Li H., Bhat C.C. Ternary complexes of liver alcohol dehydrogenase. Chem. Biol. Interact. 130:2001;371-381.
81. Jacob C., Maret W., Vallee B.L. Ebselen, a selenium-containing redox drug, releases zinc from metallothionein. Biochem. Biophys. Res. Commun. 248:1998;569-573.
82. Quintanilla M.E., Sepulveda S., Tampier L. Effect of diet and disulfiram on acetaldehyde blood levels after ethanol in Ucha and Uchb rats. Alcohol. 10:1993;381-385.
83. O'Shea B. Disulfiram revisited. Hosp. Med. 61:2000;849-851.
84. Massova I., Kotra L.P., Fridman R., Mobashery S. Matrix metalloproteinases. structures, evolution, and diversification FASEB J. 12:1998;1075-1095.
85. Gu Z.Z., Kaul M., Yan B.X., Kridel S.J., Cui J.K., Strongin A., Smith J.W., Liddington R.C., Lipton S.A. S-nitrosylation of matrix metalloproteinases. signaling pathway to neuronal cell death Science. 297:2002;1186-1190.
86. Fu X.Y., Kassim S.Y., Parks W.C., Heinecke J.W. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. J. Biol. Chem. 276:2001;41279-41287.
87. Okamoto T., Akaike T., Sawa T., Miyamoto Y., van der Vliet A., Maeda H. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J. Biol. Chem. 276:2001;29596-29602.
88. van Aalten D.M.F., Chong C.R., Joshua-Tor L. Crystal structure of carboxypeptidase A complexed with D-cysteine at 1.75 angstrom - inhibitor-induced conformational changes. Biochemistry. 39:2000;10082-10089.
89. Gomis-Ruth F.X., Maskos K., Betz M., Bergner A., Huber R., Suzuki K., Yoshida N., Nagase H., Brew K., Bourenkov G.P.et al. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature. 389:1997;77-81.
90. Perry D.K., Smyth M.J., Stennicke H.R., Salvesen G.S., Duriez P., Poirier G.G., Hannun Y.A. Zinc is a potent inhibitor of the apoptotic protease, caspase-3 - a novel target for zinc in the inhibition of apoptosis. J. Biol. Chem. 272:1997;18530-18533.
91. Lambert J.C., Wang G.W., Kang Y.J. Zinc inhibition of caspase-3 activation does not protect HeLa cells from apoptotic cell death. Toxicol. Appl. Pharmacol. 175:2001;89-93.
92. Maret W., Jacob C., Vallee B.L., Fischer E.H. Inhibitory sites in enzymes. zinc removal and reactivation by thionein Proc. Natl. Acad. Sci. USA. 96:1999;1936-1940.
93. Rodriguez-del Valle N. Effects of zinc on macromolecular-synthesis and nuclear division during the yeast to mycelium transition in Sporothrix schenckii. Mycopathologia. 106:1989;23-29.
94. Mounaji K., Vlassi M., Erraiss N.E., Wegnez M., Serrano A., Soukri A. In vitro effect of metal ions on the activity of two amphibian glyceraldehyde-3-phosphate dehydrogenases. potential metal binding sites Comp. Biochem. Physiol. B Biochem. Mol. Biol. 135:2003;241-254.
95. Jaffe E.K., Martins J., Li J., Kervinen J., Dunbrack R.L. The molecular mechanism of lead inhibition of human porphobilinogen synthase. J. Biol. Chem. 276:2001;1531-1537.
96. Gomez-Ortiz M., Gomis-Ruth F.X., Huber R., Aviles F.X. Inhibition of carboxypeptidase A by excess zinc. analysis of the structural determinants by X-ray crystallography FEBS Lett. 400:1997;336-340.
97. Larsen K.S., Auld D.S. Carboxypeptidase-A. mechanism of zinc inhibition Biochemistry. 28:1989;9620-9625.
98. Larsen K.S., Auld D.S. Characterization of an inhibitory metal-binding site in carboxypeptidase-A. Biochemistry. 30:1991;2613-2618.
99. Maret W. Oxidative metal release from metallothionein via zinc thiol-disulfide interchange. Proc. Natl. Acad. Sci. USA. 91:1994;237-241.
100. Maret W. Crosstalk of the group IIa and IIb metals calcium and zinc in cellular signaling. Proc. Natl. Acad. Sci. USA. 98:2001;12325-12327.
101. Kägi J.H.R., Schaffer A. Biochemistry of metallothionein. Biochemistry. 27:1988;8509-8515.
102. Margoshes M., Vallee B.L. A cadmium protein from equine kidney complex. J. Am. Chem. Soc. 79:1957;4813.
103. Palmiter R.D. The elusive function of metallothioneins. Proc. Natl. Acad. Sci. USA. 95:1998;8428-8430.
104. Coyle P., Philcox J.C., Carey L.C., Rofe A.M. Metallothionein. the multipurpose protein Cell. Mol. Life Sci. 59:2002;627-647.
105. Huang L.P., Kirschke C.P., Gitschier J. Functional characterization of a novel mammalian zinc transporter, ZnT6. J. Biol. Chem. 277:2002;26389-26395.
106. Kirschke C.P., Huang L.P. ZnT7, a novel mammalian zinc transporter, accumulates zinc in the Golgi apparatus. J. Biol. Chem. 278:2003;4096-4102.
107. Chimienti F., Aouffen M., Favier A., Seve M. Zinc homeostasis-regulating proteins. new drug targets for triggering cell fate Curr. Drug Targets. 4:2003;323-338.
108. Kambe T., Narita H., Yamaguchi-Iwai Y., Hirose J., Amano T., Sugiura N., Sasaki R., Mori K., Iwanaga T., Nagao M. Cloning and characterization of a novel mammalian zinc transporter, zinc transporter 5, abundantly expressed in pancreatic beta cells. J. Biol. Chem. 277:2002;19049-19055.
109. McMahon R.J., Cousins R.J. Mammalian zinc transporters. J. Nutr. 128:1998;667-670.
110. Guerinot M.L. The ZIP family of metal transporters. Biochim. Biophys. Acta. 1465:2000;190-198.
111. Gaither L.A., Eide D.J. Eukaryotic zinc transporters and their regulation. Biometals. 14:2001;251-270.
112. Radtke F., Georgiev O., Muller H.P., Brugnera E., Schaffner W. Functional domains of the heavy metal-responsive transcription regulator Mtf-1. Nucleic Acids Res. 23:1995;2277-2286.
113. Chen X.H., Agarwal A., Giedroc D.P. Structural and functional heterogeneity among the zinc fingers of human MRE-binding transcription factor-1. Biochemistry. 37:1998;11152-11161.
114. Dalton T.P., Bittel D., Andrews G.K. Reversible activation of mouse metal response element-binding transcription factor 1 DNA binding involves zinc interaction with the zinc finger domain. Mol. Cell. Biol. 17:1997;2781-2789.
115. Smirnova I.V., Bittel D.C., Ravindra R., Jiang H.M., Andrews G.K. Zinc and cadmium can promote rapid nuclear translocation of metal response element-binding transcription factor-1. J. Biol. Chem. 275:2000;9377-9384.
116. Jiang H., Daniels P.J., Andrews G.K. Putative zinc-sensing zinc-fingers of metal response element-binding transcription factor-1 stabilize a metal-dependent chromatin complex on the endogenous metallothionein-I promoter. J. Biol. Chem. 278:2003;30394-30402.
117. Giedroc D.P., Chen X.H., Pennella M.A., LiWang A.C. Conformational heterogeneity in the C-terminal zinc finers of human MTF-1. an NMR and zinc-binding study J. Biol. Chem. 276:2001;42322-42332.
118. Vašák M., Kägi J.H.R. Spectroscopic properties of metallothionein. Met. Ions Biol. Syst. 15:1983;213-273.
119. Jacob C., Maret W., Vallee B.L. Control of zinc transfer between thionein, metallothionein, and zinc proteins. Proc. Natl. Acad. Sci. USA. 95:1998;3489-3494.
120. Maret W. Cellular zinc and redox states converge in the metallothionein/thionein pair. J. Nutr. 133:2003;1460S-1462S.
121. Yang Y., Maret W., Vallee B.L. Differential fluorescence labeling of cysteinyl clusters uncovers high tissue levels of thionein. Proc. Natl. Acad. Sci. USA. 98:2001;5556-5559.
122. Maret W., Vallee B.L. Thiolate ligands in metallothionein confer redox activity on zinc clusters. Proc. Natl. Acad. Sci. USA. 95:1998;3478-3482.
123. Robbins A.H., McRee D.E., Williamson M., Collett S.A., Xuong N.H., Furey W.F., Wang B.C., Stout C.D. Refined crystal-structure of Cd, Zn metallothionein at 2.0 Å resolution. J. Mol. Biol. 221:1991;1269-1293.
124. Nettesheim D.G., Engeseth H.R., Otvos J.D. Products of metal exchange-reactions of metallothionein. Biochemistry. 24:1985;6744-6751.
125. Jiang L.J., Maret W., Vallee B.L. The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase. Proc. Natl. Acad. Sci. USA. 95:1998;3483-3488.
126. Maret W., Larsen K.S., Vallee B.L. Coordination dynamics of biological zinc "clusters" in metallothioneins and in the DNA-binding domain of the transcription factor Gal4. Proc. Natl. Acad. Sci. USA. 94:1997;2233-2237.
127. Jiang L.J., Maret W., Vallee B.L. The ATP-metallothionein complex. Proc. Natl. Acad. Sci. USA. 95:1998;9146-9149.
128. Jacob C., Maret W., Vallee B.L. Selenium redox biochemistry of zinc-sulfur coordination sites in proteins and enzymes. Proc. Natl. Acad. Sci. USA. 96:1999;1910-1914.
129. Giles G.I., Tasker K.M., Jacob C. Oxidation of biological thiols by highly reactive disulfide-S-oxides. Gen. Physiol. Biophys. 21:2002;65-72.
130. Sato M., Bremner I. Oxygen free-radicals and metallothionein. Free Radic. Biol. Med. 14:1993;325-337.
131. Chen Y., Maret W. Catalytic selenols couple the redox cycles of metallothionein and glutathione. Eur. J. Biochem. 268:2001;3346-3353.
132. Fabisiak J.P., Borisenko G.G., Liu S.X., Tyurin V.A., Pitt B.R., Kagan V.E. Redox sensor function of metallothioneins. Sen C.K., Packer L. Redox Cell Biology and Genetics, Pt B, Volume 353. 2002;Academic Press, San Diego. 268-281.pp.
133. Yoo H.Y., Chang M.S., Rho H.M. Heavy metal-mediated activation of the rat Cn/Zn superoxide dismutase gene via a metal-responsive element. Mol. Gen. Genet. 262:1999;310-313.
134. Andrews G.K. Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem. Pharmacol. 59:2000;95-104.
135. Lee S.H., Maret W. Redox control of zinc finger proteins. mechanisms and role in gene regulation Antioxid. Redox Signal. 3:2001;531-534.
136. Hainaut P., Mann K. Zinc binding and redox control of p53 structure and function. Antioxid. Redox Signal. 3:2001;611-623.
137. Fribourg S., Kellenberger E., Rogniaux H., Poterszman A., Van Dorsselaer A., Thierry J.C., Egly J.M., Moras D., Kieffer B. Structural characterization of the cysteine-rich domain of TFIIH p44 subunit. J. Biol. Chem. 275:2000;31963-31971.
138. Sun Y., Tan M.J., Duan H.J., Swaroop M.J. SAG/ROC/Rbx/Hrt, a zinc RING finger gene family. molecular cloning, biochemical properties, and biological functions Antioxid. Redox Signal. 3:2001;635-650.
139. Webster K.A., Prentice H., Bishopric N.H. Oxidation of zinc finger transcription factors. physiological consequences Antioxid. Redox Signal. 3:2001;535-548.
140. Wu X.S., Bishopric N.H., Discher D.J., Murphy B.J., Webster K.A. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol. Cell. Biol. 16:1996;1035-1046.
141. McDonnell N.B., DeGuzman R.N., Rice W.G., Turpin J.A., Summers M.F. Zinc ejection as a new rationale for the use of cystamine and related disulfide-containing antiviral agents in the treatment of AIDS. J. Med. Chem. 40:1997;1969-1976.
142. Topol I.A., McGrath C., Chertova E., Dasenbrock C., Lacourse W.R., Eissenstat M.A., Burt S.K., Henderson L.E., Casas-Finet J.R. Experimental determination and calculations of redox potential descriptors of compounds directed against retroviral zinc fingers. implications for rational drug design Protein Sci. 10:2001;1434-1445.
143. Miyanaga A., Fushinobu S., Ito K., Wakagi T. Crystal structure of cobalt-containing nitrile hydratase. Biochem. Biophys. Res. Commun. 288:2001;1169-1174.
144. Sayre L.M., Perry G., Smith M.A. Redox metals and neurodegenerative disease. Curr. Opin. Chem. Biol. 3:1999;220-225.
145. Fuchs J., Packer L. Environmental Stressors in Health and Disease. 2001;Marcel Dekker, New York.
146. Montagnier L., Olivier R., Pasquier C. Oxidative Stress in Cancer, AIDS and Neurodegenerative Diseases. 1998;Marcel Dekker, New York.
147. Ilangovan G., Li H.Q., Zweier J.L., Kuppusamy P. In vivo measurement of tumor redox environment using EPR spectroscopy. Mol. Cell. Biochem. 234:2002;393-398.
148. Rockwell S. Use of hypoxia-directed drugs in the therapy of solid tumors. Semin. Oncol. 19:1992;29-40.
149. Workman P. Enzyme-directed bioreductive drug development revisited. a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly Dt-Diaphorase Oncol. Res. 6:1994;461-475.
150. Cummings J., Spanswick V.J., Tomasz M., Smyth J.F. Enzymology of mitomycin C metabolic activation in tumour tissue. implications for enzyme-directed bioreductive drug development Biochem. Pharmacol. 56:1998;405-414.
151. Oberley T.D., Oberley L.W. Antioxidant enzyme levels in cancer. Histol. Histopathol. 12:1997;525-535.
152. Hochachka P.W., Rupert J.L., Goldenberg L., Gleave M., Kozlowski P. Going malignant. the hypoxia-cancer connection in the prostate Bioessays. 24:2002;749-757.
153. Giles N.M., Gutowski N.J., Giles G.I., Jacob C. Redox catalysts as sensitisers towards oxidative stress. FEBS Lett. 535:2003;179-182.
154. Giles G.I., Tasker K.M., Johnson R.J.K., Jacob C., Peers C., Green K.N. Electrochemistry of chalcogen compounds. prediction of antioxidant activity Chem. Commun. 23:2001;2490-2491.
155. Briviba K., Tamler R., Klotz L.O., Engman L., Cotgreave I.A., Sies H. Protection by organotellurium compounds against peroxynitrite-mediated oxidation and nitration reactions. Biochem. Pharmacol. 55:1998;817-823.
156. Giles G.I., Giles N.M., Collins C.A., Holt K., Fry F.H., Lowden P.A.S., Gutowski N.J., Jacob C. Electrochemical, in vitro and cell culture analysis of integrated redox catalysts. implications for cancer therapy Chem. Commun. 16:2003;2030-2031.
157. Fairfield K.M., Fletcher R.H. Vitamins for chronic disease prevention in adults. scientific review JAMA. 287:2002;3116-3126.
158. Brown D.J., Goodman J. A review of vitamins A, C, and E and their relationship to cardiovascular disease. Clin. Excell. Nurse Pract. 2:1998;10-22.
159. Martin A., Cherubini A., Andres-Lacueva C., Paniagua M., Joseph J. Effects of fruits and vegetables on levels of vitamins E and C in the brain and their association with cognitive performance. J. Nutr. Health Aging. 6:2002;392-404.
160. O'Hare D., Fucassi F., Cragg P.J., Green M.H.L. The voltammetric behaviour of superoxide/catalase mimics. Electroanalysis. 2:2003;164.
161. Bush A.I. Metals and neuroscience. Curr. Opin. Chem. Biol. 4:2000;184-191.
162. Taylor D.M., Williams D.R. Trace Element Medicine and Chelation Therapy. 1995;The Royal Society of Chemistry, Cambridge.
163. Graziano J.H. Conceptual and practical advances in the measurement and clinical management of lead toxicity. Neurotoxicology. 14:1993;219-224.
164. Shimizu N., Yamaguchi Y., Aoki T. Treatment and management of Wilson's disease. Pediatr. Int. 41:1999;419-422.
165. Patrick L. Mercury toxicity and antioxidants. part 1. Role of glutathione and alpha-lipoic acid in the treatment of mercury toxicity Altern. Med. Rev. 7:2002;456-471.
166. Kontoghiourghes G.J., Neocleous K., Kolnagou A. Benefits and risks of deferiprone in iron overload in thalassaemia and other conditions. comparison of epidemiological and therapeutic aspects with deferoxamine Drug Saf. 26:2003;553-584.
167. Shin R.W., Kruck T.P.A., Murayama H., Kitamoto T. A novel trivalent cation chelator Feralex dissociates binding of aluminum and iron associated with hyperphosphorylated tau of Alzheimer's disease. Brain Res. 961:2003;139-146.
168. Creighton-Gutteridge M., Tyrrell R.M. A novel iron chelator that does not induce HIF-1 activity. Free Radic. Biol. Med. 33:2002;356-363.
169. Neal R., Cooper K., Gurer H., Ercal N. Effects of N-acetylcysteine and 2,3-dimercaptosuccinic acid on lead induced oxidative stress in rat lenses. Toxicology. 130:1998;167-174.
170. Andreassen O.A., Dedeoglu A., Klivenyi P., Beal M.F., Bush A.I. N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis. Neuroreport. 11:2000;2491-2493.
171. Fernandez-Pol J.A., Hamilton P.D., Klos D.J. Essential viral and cellular zinc and iron containing metalloproteins as targets for novel antiviral and anticancer agents. implications for prevention and therapy of viral diseases and cancer Anticancer Res. 21:2001;931-957.
172. Ritz D., Lim J., Reynolds C.M., Poole L.B., Beckwith J. Conversion of a peroxiredoxin into a disulfide reductase by a triplet repeat expansion. Science. 294:2001;158-160.
173. Woo H.A., Chae H.Z., Hwang S.C., Yang K.S., Kang S.W., Kim K., Rhee S.G. Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation. Science. 300:2003;653-656.
174. Wood Z.A., Poole L.B., Karplus P.A. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science. 300:2003;650-653.
175. Choi H.J., Kim S.J., Mukhopadhyay P., Cho S., Woo J.R., Storz G., Ryu S.E. Structural basis of the redox switch in the OxyR transcription factor. Cell. 105:2001;103-113.
176. QUANTA2000 Generating and Displaying Molecules. 1997;Molecular Simulations, San Diego.
177. Bode J., Blumenstein M., Raftery M. Non-identical alkylation sites in rabbit muscle glyceraldehyde-3-phosphate dehyrodrogenase. Biochemistry. 14:1975;1146-1152.
178. Morgunova E., Tuuttila A., Bergmann U., Tryggvason K. Structural insight into the complex formation of latent matrix metalloproteinase 2 with tissue inhibitor of metalloproteinase 2. Proc. Natl. Acad. Sci. USA. 99:2002;7414-7419.
179. Fernandez-Catalan C., Bode W., Huber R., Turk D., Calvete J.J., Lichte A., Tschesche H., Maskos K. Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor. EMBO J. 17:1998;5238-5248.